Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Avogaro

Showing results (101-110 of 426) with videos related to

Pageof 43
Sort By:
Cardiovascular Endocrinology & Metabolism|October 25, 2019
The impact of glucose-lowering medications on cardiovascular diseaseAngelo Avogaro, Saula Vigili De Kreutzenberg, Gian Paolo Fadini
Gerontology|August 20, 2005
Oral amino acids in elderly subjects: effect on myocardial function and walking capacityRoldano Scognamiglio, Roberto Piccolotto, Christian Negut, et al.
Journal of Refractive Surgery (Thorofare, N.J. : 1995)|April 21, 2007
Corneal diabetic neuropathy: a confocal microscopy studyEdoardo Midena, Erica Brugin, Alessandra Ghirlando, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 12, 2026
Implementing SGLT2 Inhibitors in Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Multidisciplinary Expert PerspectiveAngelo Avogaro, Mauro Gori, Giuseppe Grandaliano, et al.
World Journal of Surgery|July 21, 2006
Laparoscopic treatment of benign insulinomas localized in the body and tail of the pancreas: a single-center experienceAntonio Toniato, Francesco Meduri, Mirto Foletto, et al.
Nutrition & Diabetes|January 8, 2021
Efficacy of telemedicine for persons with type 1 diabetes during Covid19 lockdownFederico Boscari, Sara Ferretto, Ambra Uliana, et al.
Cardiovascular Diabetology|February 12, 2021
SGLT-2 inhibitors and atrial fibrillation in the Food and Drug Administration adverse event reporting systemBenedetta Maria Bonora, Emanuel Raschi, Angelo Avogaro, et al.
Diabetes, Obesity & Metabolism|November 8, 2021
Challenges and opportunities in real-world evidence on the renal effects of sodium-glucose cotransporter-2 inhibitorsGian Paolo Fadini, Stefano Del Prato, Angelo Avogaro, et al.
The Journal of Clinical Endocrinology and Metabolism|June 19, 2019
Angiogenic Abnormalities in Diabetes Mellitus: Mechanistic and Clinical AspectsGian Paolo Fadini, Mattia Albiero, Benedetta Maria Bonora, et al.
Journal of the American College of Cardiology|January 3, 2006
Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitusRoldano Scognamiglio, Christian Negut, Angelo Ramondo, et al.
Pageof 43

Showing results (101-110 of 426) with videos related to

Sort By:
Pageof 43
Cardiovascular Endocrinology & Metabolism|October 25, 2019
The impact of glucose-lowering medications on cardiovascular diseaseAngelo Avogaro, Saula Vigili De Kreutzenberg, Gian Paolo Fadini
Gerontology|August 20, 2005
Oral amino acids in elderly subjects: effect on myocardial function and walking capacityRoldano Scognamiglio, Roberto Piccolotto, Christian Negut, et al.
Journal of Refractive Surgery (Thorofare, N.J. : 1995)|April 21, 2007
Corneal diabetic neuropathy: a confocal microscopy studyEdoardo Midena, Erica Brugin, Alessandra Ghirlando, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 12, 2026
Implementing SGLT2 Inhibitors in Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Multidisciplinary Expert PerspectiveAngelo Avogaro, Mauro Gori, Giuseppe Grandaliano, et al.
World Journal of Surgery|July 21, 2006
Laparoscopic treatment of benign insulinomas localized in the body and tail of the pancreas: a single-center experienceAntonio Toniato, Francesco Meduri, Mirto Foletto, et al.
Nutrition & Diabetes|January 8, 2021
Efficacy of telemedicine for persons with type 1 diabetes during Covid19 lockdownFederico Boscari, Sara Ferretto, Ambra Uliana, et al.
Cardiovascular Diabetology|February 12, 2021
SGLT-2 inhibitors and atrial fibrillation in the Food and Drug Administration adverse event reporting systemBenedetta Maria Bonora, Emanuel Raschi, Angelo Avogaro, et al.
Diabetes, Obesity & Metabolism|November 8, 2021
Challenges and opportunities in real-world evidence on the renal effects of sodium-glucose cotransporter-2 inhibitorsGian Paolo Fadini, Stefano Del Prato, Angelo Avogaro, et al.
The Journal of Clinical Endocrinology and Metabolism|June 19, 2019
Angiogenic Abnormalities in Diabetes Mellitus: Mechanistic and Clinical AspectsGian Paolo Fadini, Mattia Albiero, Benedetta Maria Bonora, et al.
Journal of the American College of Cardiology|January 3, 2006
Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitusRoldano Scognamiglio, Christian Negut, Angelo Ramondo, et al.
Pageof 43